Cargando…

Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer

Molecular profiling of circulating cell-free DNA (cfDNA) has shown utility for the management of colorectal cancer (CRC). TruSight Tumor 170 (TST170) is a next-generation sequencing (NGS) panel that covers 170 cancer-related genes, including KRAS, which is a key driver gene in CRC. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Casanova, Aitor, Bao-Caamano, Aida, Lago-Lestón, Ramón M., Brozos-Vázquez, Elena, Costa-Fraga, Nicolás, Ferreirós-Vidal, Isabel, Abdulkader, Ihab, Vidal-Insua, Yolanda, Rivera, Francisca Vázquez, Candamio Folgar, Sonia, López-López, Rafael, Muinelo-Romay, Laura, Diaz-Lagares, Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509146/ https://www.ncbi.nlm.nih.gov/pubmed/34640513 http://dx.doi.org/10.3390/jcm10194487

Ejemplares similares

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
por: Vidal Insua, Yolanda, et al.
Publicado: (2017)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
por: Ruiz-Bañobre, Juan, et al.
Publicado: (2022)

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
por: Rodriguez-Casanova, Aitor, et al.
Publicado: (2021)

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy
por: Pérez-Martelo, Martín, et al.
Publicado: (2022)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next‐generation sequencing panel: A preliminary study
por: Rapado‐González, Óscar, et al.
Publicado: (2022)

A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer
por: Rodriguez-Casanova, Aitor, et al.
Publicado: (2022)

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
por: Muinelo-Romay, Laura, et al.
Publicado: (2014)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
por: Brozos-Vázquez, E. M., et al.
Publicado: (2023)

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
por: Vidal, J, et al.
Publicado: (2017)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
por: Abreu, Manuel, et al.
Publicado: (2020)

Integrity and quantity of salivary cell‐free DNA as a potential molecular biomarker in oral cancer: A preliminary study
por: Rapado‐González, Óscar, et al.
Publicado: (2022)

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
por: Martínez-Lago, Nieves, et al.
Publicado: (2021)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis
por: Rapado-González, Óscar, et al.
Publicado: (2021)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method
por: Fernández Montes, Ana, et al.
Publicado: (2021)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model
por: López-Cortés, Rubén, et al.
Publicado: (2022)

Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity
por: Rapado-González, Óscar, et al.
Publicado: (2016)

Interspecific Introgression in Cetaceans: DNA Markers Reveal Post-F1 Status of a Pilot Whale
por: Miralles, Laura, et al.
Publicado: (2013)

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer
por: Mariscal, Javier, et al.
Publicado: (2016)

Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020)

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
por: Vila, Ana, et al.
Publicado: (2016)

Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells
por: López-Cortés, Rubén, et al.
Publicado: (2023)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022)

Liquid Biopsy in Oral Cancer
por: Lousada-Fernandez, Fatima, et al.
Publicado: (2018)

Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Morphological Abnormalities and Gene Expression Changes Caused by High Incubation Temperatures in Zebrafish Xenografts with Human Cancer Cells
por: Cabezas-Sainz, Pablo, et al.
Publicado: (2021)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
por: Abreu, Manuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rpumh118rugs44ve9jkp1rpm77